Company Valuation: Dr. Reddy's Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 714,500 767,655 1,024,969 953,168 1,044,616 1,153,806 - -
Change - 7.44% 33.52% -7.01% 9.59% 10.45% - -
Enterprise Value (EV) 1 703,980 719,330 960,383 928,633 1,011,902 1,123,463 1,104,550 1,077,877
Change - 2.18% 33.51% -3.31% 8.97% 11.02% -1.68% -2.41%
P/E 30.4x 17.1x 18.4x 16.9x 24.4x 31.5x 23.7x 20.1x
PBR 3.76x 3.33x 3.63x 2.86x 2.78x 2.83x 2.57x 2.33x
PEG - 0.2x 0.8x 13.12x -1x -2.2x 0.7x 1.1x
Capitalization / Revenue 3.33x 3.11x 3.67x 2.93x 3.11x 3.28x 2.93x 2.67x
EV / Revenue 3.28x 2.92x 3.44x 2.85x 3.01x 3.2x 2.81x 2.49x
EV / EBITDA 13.7x 11.1x 12.1x 10.8x 15.1x 17.9x 13.7x 11.7x
EV / EBIT 20.5x 13.8x 14.8x 13.4x 21.8x 27x 19.1x 15.8x
EV / FCF 52.3x 15.1x 33.1x 49.1x 30.3x 31.2x 33.3x 24.8x
FCF Yield 1.91% 6.61% 3.02% 2.04% 3.3% 3.2% 3% 4.03%
Dividend per Share 2 6 8 8 8 8 7.482 8.373 9.13
Rate of return 0.7% 0.87% 0.65% 0.7% 0.64% 0.54% 0.6% 0.66%
EPS 2 28.34 54.18 66.92 67.78 51.42 43.98 58.39 68.78
Distribution rate 21.2% 14.8% 12% 11.8% 15.6% 17% 14.3% 13.3%
Net sales 1 214,391 246,697 279,164 325,535 335,933 351,282 393,171 432,374
EBITDA 1 51,400 64,559 79,481 86,236 67,048 62,797 80,785 92,091
EBIT 1 34,277 52,057 64,781 69,178 46,443 41,656 57,771 68,088
Net income 1 23,568 45,073 55,779 56,544 42,850 36,498 49,207 57,692
Net Debt 1 -10,520 -48,325 -64,586 -24,535 -32,714 -30,343 -49,256 -75,929
Reference price 2 861.08 924.30 1,231.03 1,144.05 1,254.65 1,385.00 1,385.00 1,385.00
Nbr of stocks (in thousands) 829,771 830,526 832,611 833,152 832,596 833,073 - -
Announcement Date 5/19/22 5/10/23 5/7/24 5/9/25 5/12/26 - - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
31.13x3.16x17.68x0.55% 12.31B
39.62x13.42x28.51x0.5% 1,258B
40.43x6.79x19.09x1.93% 679B
37.52x8.51x17.57x2.38% 518B
20.98x5.12x12.74x2.57% 390B
104.15x5.94x25.33x2.32% 367B
23.47x5.94x14.26x2.69% 307B
24.46x4.89x13.77x1.79% 293B
23.75x7.3x13.55x2.19% 252B
-39.18x7.27x45.77x1.98% 210B
Average 30.63x 6.83x 20.83x 1.89% 429B
Weighted average by Cap. 36.31x 8.57x 21.90x 1.72%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Dr. Reddy's Laboratories Limited

Historical PBR trend

Valuation ratios - PBR - Dr. Reddy's Laboratories Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Dr. Reddy's Laboratories Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Dr. Reddy's Laboratories Limited


Year-on-year evolution of the Yield

Valuation ratios - Yield - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock
  4. Valuation Dr. Reddy's Laboratories Limited